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Surveillance programmes for hepatocellular carcinoma: evident-based medicine
is not evidence-based medicine
To the Editor:
The paper concerning surveillance programmes for hepato-
cellular carcinoma (HCC) in the journal needs one clariﬁcation
(1).
Indeed, survival is lower when the diagnosis is made late
than soon, and whenthe patient is older. However, this does not
demonstrate the usefulness of surveillance. Several biases exist,
the main being the lead-time bias. Again, here is an example
concerning HCC. In a recent study, screened patients died 18
months earlier than non-screened ones; nevertheless, the
authors concluded that screening improved survival (2)! Nu-
merous studies have investigated screening; all were negative or
inconclusive (3, 4).
Moreover, at present, no randomized-controlled trials are
available to choose potentially curative treatments for small
HCC: transplantation, resection and local ablation.
Alain Braillon
Public Health, University Hospitals Amiens, France
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